Dr. Shiskuka Malhotra, MD
Claim this profileNeuro-Behavioral Clinical Research
Studies Schizophrenia
Studies Alzheimer's Disease
11 reported clinical trials
16 drugs studied
Affiliated Hospitals
Clinical Trials Shiskuka Malhotra, MD is currently running
KYN-5356
for Schizophrenia
This is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of 3 different dose regiments of KYN-5356 and placebo for 28 days. Participants will be randomized to one of 4 treatment groups: placebo, KYN-5356 low dose, KYN-5356 medium dose, KYN-5356 high dose. Participants will be admitted to the clinic on Day -3 and will remain in residence at the clinic for 32 days, from baseline through the treatment period. Participants will be administered investigational medicinal product on Days 1 through 28. Efficacy, safety, PK and exploratory PD assessments will be performed throughout the dosing period. Participants will be discharged on Day 29 after safety assessments are completed and return for a follow-up visit on Day 42. A subset of participants from selected sites will undergo electrophysiological assessments to evaluate the effect of KYN-5356 on neurophysiological measures of brain function.
Recruiting0 awards Phase 22 criteria
PMN310
for Alzheimer's Disease
This Phase 1b study aims to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of multiple IV infusions of PMN310 in patients with early Alzheimer's disease.
Recruiting0 awards Phase 12 criteria
More about Shiskuka Malhotra, MD
Clinical Trial Related4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Shiskuka Malhotra, MD has experience with
- Placebo
- SEP-4199 CR 200 Mg
- SEP-4199 CR 400 Mg
- LB-102
- Etavopivat
- CVL-231
Breakdown of trials Shiskuka Malhotra, MD has run
Schizophrenia
Alzheimer's Disease
Bipolar Depression
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shiskuka Malhotra, MD specialize in?
Shiskuka Malhotra, MD focuses on Schizophrenia and Alzheimer's Disease. In particular, much of their work with Schizophrenia has involved treating patients, or patients who are undergoing treatment.
Is Shiskuka Malhotra, MD currently recruiting for clinical trials?
Yes, Shiskuka Malhotra, MD is currently recruiting for 2 clinical trials in North Canton Ohio. If you're interested in participating, you should apply.
Are there any treatments that Shiskuka Malhotra, MD has studied deeply?
Yes, Shiskuka Malhotra, MD has studied treatments such as Placebo, SEP-4199 CR 200 mg, SEP-4199 CR 400 mg.
What is the best way to schedule an appointment with Shiskuka Malhotra, MD?
Apply for one of the trials that Shiskuka Malhotra, MD is conducting.
What is the office address of Shiskuka Malhotra, MD?
The office of Shiskuka Malhotra, MD is located at: Neuro-Behavioral Clinical Research, North Canton, Ohio 44720 United States. This is the address for their practice at the Neuro-Behavioral Clinical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.